Joanna E. Zawacka-Pankau
Huddinge, AB 14186, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
p53 biology and reactivation for improved therapy in MDS and AML.
Journal: Biomarker research
Published: January 06, 2024
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Journal: Cell death and differentiation
Published: January 30, 2023
The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer.
Journal: International journal of molecular sciences
Published: June 09, 2022
Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule.
Journal: Frontiers in molecular biosciences
Published: November 29, 2021
The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity.
Journal: International journal of molecular sciences
Published: July 02, 2021
Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression.
Journal: Blood
Published: March 12, 2021
The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing.
Journal: Cancers
Published: August 21, 2020
The p53/MDM2/MDMX-targeted therapies-a clinical synopsis.
Journal: Cell death & disease
Published: January 28, 2020
Correction: APR-246 reactivates mutant p53 by targeting cysteines 124 and 277.
Journal: Cell death & disease
Published: October 12, 2019
Correction to: Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells.
Journal: Cell division
Published: September 06, 2019
Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells.
Journal: Cell death discovery
Published: February 07, 2019
Last Updated: 09/26/2026